Company: IVHI
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001683168-25-003408
Chunk: 12

Company: Invech Holdings, Inc.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 1
Chunk 12
---
 companies. Revenues are generated through the preparation of SEC regulation documents such as S-1 filings, Form 10 filings,
and 8-K filings, FINRA Corporate Action filings and OTC Markets filings.

Operations

Our company is headquartered in Scottsdale, Arizona,
where our executive, administrative and operational management are based. To date, the Company has begun implementing its business plan
and is attempting to secure additional funding to continue expansion of our services and products.  The Company has not had any significant
revenues generated from its business operations since inception.  Until the Company is able to generate any consistent and significant
revenue, it may be required to raise additional funds by way of equity or debt financing.

 13 

Our Market

Microcap public company compliance is increasingly
important and expanding after amendments to Rule 15c2-11. The amendments were adopted to enhance investor protection by requiring that
microcap public companies, specifically pink sheet companies listed on OTC Markets, to become more transparent via expanded regulatory
compliance.

Results of Operations

Introduction

The financial statements
appearing elsewhere in this report have been prepared assuming the Company will continue as a going concern. The Company was recently
formed and has not established sufficient operations or revenues to sustain the Company. These conditions raise substantial doubt about
the Company’s ability to continue as a going concern.

To date, the Company has
relied on debt and equity raised in private offerings and shareholder loans to finance operations and no other sources of capital has
been identified. If we experience a shortfall in operating capital, we could be faced with having to limit our research and development
activities.

Results of Operations
for the Three Months Ended March 30, 2025, and 2024

Revenue

For the three
months ended March 31, 2025, and 2024, the Company had not generated any revenues.

Operating Expenses

Operating expenses for the
three months ended March 31, 2025 were $31,377 compared to $29,618 for the three months ended March 31, 2024, an increase of $1,759.

Operating expenses increased
in 2024 due to a decrease in professional fees and other general and administrative fees incurred for this period.

Net Loss

For the three months ended
March 31, 2025, the Company had a net loss of $31,377 compared to the three months ended March 31, 2024 of a net loss of $